Friedrich Fahnert

Array ( [id] => 8251928 [patent_doc_number] => 20120156245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Methods for the Prevention of Malaria' [patent_app_type] => utility [patent_app_number] => 13/093754 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10729 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156245.pdf [firstpage_image] =>[orig_patent_app_number] => 13093754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659111 [patent_doc_number] => 20130039941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'VACCINE COMPRISING INACTIVATED CELLS OF HAEMOPHILUS PARASUIS BACTERIA OF SEROTYPE 5' [patent_app_type] => utility [patent_app_number] => 13/642705 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4252 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015684 [patent_doc_number] => 20110223608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'MOLECULAR DETECTION AND QUANTIFICATION OF ENTEROCOCCI' [patent_app_type] => utility [patent_app_number] => 13/089146 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1335 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223608.pdf [firstpage_image] =>[orig_patent_app_number] => 13089146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510884 [patent_doc_number] => 20110256612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COMPOSITIONS FOR CULTURING SPIROCHETES' [patent_app_type] => utility [patent_app_number] => 13/083239 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14800 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256612.pdf [firstpage_image] =>[orig_patent_app_number] => 13083239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273122 [patent_doc_number] => 08637049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Attenuated live vaccines for aquatic animals' [patent_app_type] => utility [patent_app_number] => 13/081134 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 22280 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13081134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500441 [patent_doc_number] => 20110262954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'SHUTTLE VECTOR BASED TRANSFORMATION SYSTEM FOR PYROCOCCUS FURIOSUS' [patent_app_type] => utility [patent_app_number] => 13/048329 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17605 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262954.pdf [firstpage_image] =>[orig_patent_app_number] => 13048329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659117 [patent_doc_number] => 20130039947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF' [patent_app_type] => utility [patent_app_number] => 13/634357 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14955 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710303 [patent_doc_number] => 20120003256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'TUBERCULOSIS ANTIGENS, IMMUNOGENIC COMPOSITIONS, DIAGNOSTICS AND METHODS RELATED TO THE SAME' [patent_app_type] => utility [patent_app_number] => 13/038288 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23282 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13038288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989427 [patent_doc_number] => 09034628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Induction of gene expression using a high concentration sugar mixture' [patent_app_type] => utility [patent_app_number] => 13/029940 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 10975 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10499794 [patent_doc_number] => 09228191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Transfection vector' [patent_app_type] => utility [patent_app_number] => 13/015918 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 22585 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13015918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892562 [patent_doc_number] => 08916172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'MVA expressing modified HIV envelope, gag, and pol genes' [patent_app_type] => utility [patent_app_number] => 12/987791 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 67 [patent_no_of_words] => 17476 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12987791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489116 [patent_doc_number] => 20120288523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI' [patent_app_type] => utility [patent_app_number] => 13/519011 [patent_app_country] => US [patent_app_date] => 2011-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2747 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927590 [patent_doc_number] => 20130183350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'IMMUNOGENIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/515093 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22843 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393188 [patent_doc_number] => 20120231033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'INACTIVATED POULTRY VACCINE' [patent_app_type] => utility [patent_app_number] => 13/510640 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4741 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054583 [patent_doc_number] => 20110110943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING' [patent_app_type] => utility [patent_app_number] => 12/952048 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37753 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110943.pdf [firstpage_image] =>[orig_patent_app_number] => 12952048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482867 [patent_doc_number] => 20120282274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'TARGETING OF THE C-TERMINAL SEGMENT OF C.DIFFICILE TOXIN B FOR IMPROVED CLINICAL DIAGNOSIS, PREVENTION, AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/508791 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18056 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405476 [patent_doc_number] => 20120237537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'METHODS FOR PRODUCING AN IMMUNE RESPONSE TO TUBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 13/510862 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21326 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393185 [patent_doc_number] => 20120231029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'ENHANCED MALARIA MSP-1 SUBUNIT VACCINE' [patent_app_type] => utility [patent_app_number] => 13/510923 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10454 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482886 [patent_doc_number] => 20120282293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Multivalent Live Vector Vaccine against Clostridium difficile-Associated Disease' [patent_app_type] => utility [patent_app_number] => 13/509818 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17814 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683919 [patent_doc_number] => 20130052204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => '(POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE' [patent_app_type] => utility [patent_app_number] => 13/508860 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12021 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508860 [rel_patent_id] =>[rel_patent_doc_number] =>)